logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Class
    3. Opioid Antagonist

    Opioid Antagonist class drugs

    FiltersReset Filters
    21 results

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Medication Details
      Dr.Reddys Laboratories Inc
      Usage: Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence, to be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
      Medication Details
      Drug Interactions

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Medication Details
      Dr.Reddys Laboratories Inc
      Usage: Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
      Medication Details
      Drug Interactions

    • buprenorphine hydrochloride and naloxone hydrochloride dihydrate

      (Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate)
      Medication Details
      SpecGx LLC
      Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used in conjunction with a comprehensive treatment plan that includes counseling and psychosocial support.
      Medication Details
      Drug Interactions

    • contrave

      (naltrexone hydrochloride and bupropion hydrochloride)
      Medication Details
      Nalpropion Pharmaceuticals LLC
      Usage: CONTRAVE is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater (obese) or 27 kg/m² or greater (overweight) with weight-related comorbid conditions, as an adjunct to diet and exercise. Safety with other weight loss products is not established.
      Medication Details
      Drug Interactions

    • movantik

      (naloxegol oxalate)
      Medication Details
      RedHill Biopharma Ltd
      Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not require frequent opioid dosage increases.
      Medication Details
      Drug Interactions

    • movantik

      (naloxegol oxalate)
      Medication Details
      Valinor Pharma, LLC
      Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to previous cancer or treatment, who do not require frequent opioid dosage increases.
      Medication Details
      Drug Interactions

    • naloxone hydrochloride

      (naloxone hydrochloride)
      Medication Details
      Baxter Healthcare Corporation
      Usage: Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid-induced respiratory depression and for diagnosing opioid overdose. It may also serve as an adjunct to increase blood pressure in septic shock management.
      Medication Details
      Drug Interactions

    • naloxone hydrochloride

      (Naloxone Hydrochloride)
      Medication Details
      Mylan Institutional LLC
      Usage: Naloxone hydrochloride injection is indicated for reversing opioid depression, including respiratory depression from various opioids. It is also used for diagnosing acute opioid overdose and may assist in increasing blood pressure in septic shock management.
      Medication Details
      Drug Interactions

    • naloxone hydrochloride

      (Naloxone Hydrochloride)
      Medication Details
      BPI Labs LLC
      Usage: Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid-induced respiratory depression and for diagnosing acute opioid overdosage. It may also be used as an adjunctive agent to raise blood pressure in the management of septic shock.
      Medication Details
      Drug Interactions

    • naloxone hydrochloride

      (NALOXONE HYDROCHLORIDE)
      Medication Details
      Baxter Healthcare Corporation
      Usage: Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid-induced respiratory depression and for diagnosing acute opioid overdose. It may also be used as an adjunct to increase blood pressure in septic shock management.
      Medication Details
      Drug Interactions